Prostate Cancer Screening in the MR Imaging Era: Evidence, Strategies, and Future Directions

Area of Science:

• Radiology and Oncology
• Medical Imaging
• Artificial Intelligence in Healthcare

Background:

• Prostate cancer screening traditionally relies on PSA testing and DRE, often leading to overdiagnosis of indolent disease.
• Emerging technologies like MR imaging offer improved visualization of the prostate.
• Artificial intelligence (AI) is increasingly integrated into medical workflows for enhanced analysis.

Purpose of the Study:

• To review recent advancements in MR imaging for prostate cancer screening.
• To evaluate the utility of AI in conjunction with MR imaging for prostate cancer diagnosis.
• To discuss risk-adjusted screening strategies and future directions in prostate cancer care.

Main Methods:

• Synthesis of recent literature on MR imaging and AI in prostate cancer screening.
• Analysis of evidence supporting the diagnostic accuracy of MR imaging.
• Review of AI applications in image reconstruction and lesion detection.

Main Results:

• MR imaging combined with AI improves the identification of clinically significant prostate cancer.
• AI enhances diagnostic accuracy and accessibility in prostate cancer screening.
• Risk-adjusted strategies and AI integration show promise for personalized screening.

Conclusions:

• MR imaging and AI represent a paradigm shift in prostate cancer screening.
• These technologies enhance precision, reduce overdiagnosis, and improve access to care.
• Future research should focus on further optimizing AI applications for equitable prostate cancer management.